Clinical trial · Interventional
18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound
Use of 18F-FLT Positron Emission Tomography to Evaluate the Suspicious Findings on Mammography and Breast Ultrasound: A Pilot Study
NCT01713049CI-TRIAL-00008329unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose: To investigate the diagnostic accuracy of 18F-FLT PET for the suspicious lesions on mammograms and ultrasound.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 18F-FLT | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- 18F-FLT
- description
- 18F-FLT PET for Suspicious Findings on Mammography and Breast Ultrasound.
- interventionNames
- Drug: 18F-FLT
Primary outcomes (1)
- measure
- To investigate the diagnostic accuracy of 18F-FLT PET for the suspicious lesions on mammograms and ultrasound, using the pathologic result of biopsy as gold standard.
- timeFrame
- The biopsy procedures will be scheduled as soon as possible and should be finished within 2 months after 18F-FLT PET.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Women aged between 20 to 80 years 2. women who have localized findings on mammography and / or ultrasound and will receive biopsy. 3. The lesions on the conventional imaging measure \>=1cm 4. WBC count \>=3000/L, or platelet\>=75,000/L 5. Liver function, AST or ALT \< 78 U/L 6. Renal function, Creatinine \< 2.0 mg/dl.The laboratory examinations should be performed within 4months before our study. Exclusion Criteria: 1. Pregnant women or who are planning to be pregnant. 2. Known cancers in other organs. 3. Women who are not able to cooperate with the PET/CT examination.
References
Publications (0)
Data not yet available
No reference posted for this study.